Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Outcomes of Patients With Solid Tumor Treated on Phase I Clinical Trials Within a Comprehensive Cancer Center's Private and Safety-Net Hospitals.
Journal: JCO oncology practice
Published: December 03, 2025
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: November 23, 2025
Thrombotic Thrombocytopenic Purpura in a Patient With Triple-Negative Breast Cancer Treated With PD-L1 Inhibition and Taxane Chemotherapy.
Journal: Clinical case reports
Published: November 11, 2025
Androgen receptor as a therapeutic target in endometrial cancer: a narrative review.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 05, 2025
Isoform specific regulation of osteopontin by AKT2 in hepatocytes and livers.
Journal: Cellular signalling
Published: April 02, 2025
Characterizing Kupffer Cell Production of CD5 Antigen-Like and Its Function on Regulating Migration of Natural Killer T Cells.
Journal: The American journal of pathology
Published: December 07, 2024
A Dynamic, D-dimer-based Thromboprophylaxis Strategy in Patients with COVID-19.
Journal: F1000Research
Published: October 14, 2024
Proinflammatory macrophages release CXCL5 to regulate T cell function and limit effects of αPD-1 in steatosis-driven liver cancer.
Journal: JHEP reports : innovation in hepatology
Published: May 14, 2024
Post-stem cell transplant maintenance in FLT3mut acute myeloid leukemia - A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib.
Journal: EJHaem
Published: January 11, 2024
WITHDRAWN: A dynamic, D-dimer-based thromboprophylaxis strategy in patients with COVID-19.
Journal: Thrombosis update
Published: June 08, 2021
Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series.
Journal: Annals of hematology
Published: March 28, 2020
Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post-haploidentical allogeneic stem cell transplant.
Journal: British journal of haematology
Published: May 22, 2019
Last Updated: 09/26/2026